Associate Professor Wendy Cooper

Clinical Associate Professor
Medicine, Central Clinical School

Telephone 02 95157458

Map

Biographical details

Wendy Cooper is a Staff Specialist in Tissue Pathology and Diagnostic Oncology at Royal Prince Alfred Hospital in Sydney and has a special interest in lung cancer and lymphomas. She graduated from Medicine at the University of Sydney with First Class Honours in 1998. She obtained her Fellowship from the Royal Australasian College of Pathologists in 2004. In 2008 Wendy obtained a PhD from the University of Sydney with a thesis titled “Molecular makers of prognosis in early stage non-small cell lung cancer”.

She now specialises in pulmonary pathology and has a particular interest in lung cancer and genetic testing of cancers for personalised medicine. She is a member of Multidisciplinary working party revising Clinical Practice Guidelines for the Prevention, Diagnosis and Management of Lung Cancer for Cancer Council Australia. She is also a member of Lung Expert Group for development of Lung Cancer Structured Reporting Protocol for the RCPA and Cancer Institute NSW. Wendy is also a member of the Australian Lung cancer Trials Group, a cooperative clinical trials group aiming to improve outcome and quality of life in lung cancer. Wendy is Chair of the Lung Club for the Australasian Division of the International Academy of Pathology. She is a member of the Australian Lung cancer Trials Group

Wendy is a Visiting Scientist at the Garvan Institute of Medical Research. Her major research interest is in prognostic and predictive biomarkers in lung cancer with current projects including analysis of ALK and ROS1 gene rearrangements, EGFR mutations as well as MET and FGFR1 amplifcation in non-small cell lung cancer. She has published over 30 peer-reviewed publications with 14 as first or senior author. Wendy has written 5 invited review papers related to lung cancer and has given over 15 invited lectures at local and international conferences.

Research interests

Lung cancer

Lymphoma

Teaching and supervision

Lung pathology

Haematopathology

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Houang, M., Sioson, L., Clarkson, A., Watson, N., Mahtab, F., Toon, C., Raut, A., O'Toole, S., Cooper, W., Pavlakis, N., Gill, A., et al (2014). EGFR mutation specific immunohistochemistry is a useful adjunct which helps to identify false negative mutation testing in lung cancer. Pathology, 46(6), 501-508.
  • Cooper, W., Fox, S., O'Toole, S., Morey, A., Frances, G., Pavlakis, N., OBrien, K., Dettrick, A., Leong, T., et al (2014). National Working Group Meeting on ALK diagnostics in lung cancer. Asia-Pacific Journal of Clinical Oncology, 12(SUPPL. 2), 11-17. [More Information]
  • Houang, M., Toon, C., Clarkson, A., Sioson, L., Watson, N., Farzin, M., Selinger, C., Chou, A., Morey, A., Cooper, W., O'Toole, S., Gill, A. (2014). Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer. Pathology, 46(5), 383-388. [More Information]
  • Cooper, W., Solomon, B. (2014). Response to mahe. Modern Pathology, 27(10), 1424-1425.
  • Cooper, W., Lam, D., O'Toole, S., Minna, J. (2013). Molecular biology of lung cancer. Journal of Thoracic Disease, 5(S5), S479-S490. [More Information]
  • Lau, E., Cooper, W., Bye, P., Yan, K. (2011). Difficult asthma and Churg-Strauss-like syndrome: A cautionary tale. Respirology, 16(1), 180-181. [More Information]
  • Cooper, W., Shingde, M., Lee, V., Allan, R., Wills, E., Harper, C. (2004). "Rhabdoid Meningioma" Lacking Malignant Features. Report Of Two Cases. Clinical Neuropathology, 23(1), 16-20.

2014

  • Houang, M., Sioson, L., Clarkson, A., Watson, N., Mahtab, F., Toon, C., Raut, A., O'Toole, S., Cooper, W., Pavlakis, N., Gill, A., et al (2014). EGFR mutation specific immunohistochemistry is a useful adjunct which helps to identify false negative mutation testing in lung cancer. Pathology, 46(6), 501-508.
  • Cooper, W., Fox, S., O'Toole, S., Morey, A., Frances, G., Pavlakis, N., OBrien, K., Dettrick, A., Leong, T., et al (2014). National Working Group Meeting on ALK diagnostics in lung cancer. Asia-Pacific Journal of Clinical Oncology, 12(SUPPL. 2), 11-17. [More Information]
  • Houang, M., Toon, C., Clarkson, A., Sioson, L., Watson, N., Farzin, M., Selinger, C., Chou, A., Morey, A., Cooper, W., O'Toole, S., Gill, A. (2014). Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer. Pathology, 46(5), 383-388. [More Information]
  • Cooper, W., Solomon, B. (2014). Response to mahe. Modern Pathology, 27(10), 1424-1425.

2013

  • Cooper, W., Lam, D., O'Toole, S., Minna, J. (2013). Molecular biology of lung cancer. Journal of Thoracic Disease, 5(S5), S479-S490. [More Information]

2011

  • Lau, E., Cooper, W., Bye, P., Yan, K. (2011). Difficult asthma and Churg-Strauss-like syndrome: A cautionary tale. Respirology, 16(1), 180-181. [More Information]

2004

  • Cooper, W., Shingde, M., Lee, V., Allan, R., Wills, E., Harper, C. (2004). "Rhabdoid Meningioma" Lacking Malignant Features. Report Of Two Cases. Clinical Neuropathology, 23(1), 16-20.

To update your profile click here. For support on your academic profile contact .